Levera 1000 Tablet contains Levetiracetam 1000mg, an antiepileptic medication indicated for the treatment of partial-onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, thereby reducing neuronal excitability and seizure propagation. This medication is used as monotherapy or adjunctive therapy in adults and pediatric patients aged four years and above. Levera 1000 Tablet is administered orally, with dosage individualized based on clinical response and tolerability. Common adverse effects include somnolence, dizziness, fatigue, and behavioral changes such as irritability or agitation. It is important to monitor patients for mood alterations and suicidal ideation during therapy. Levetiracetam has minimal drug interactions due to its renal excretion and lack of hepatic metabolism, making it suitable for patients on multiple medications. Caution is advised in patients with renal impairment, where dose adjustment is necessary. Levera 1000 Tablet should be used under strict medical supervision, and abrupt discontinuation should be avoided to prevent seizure exacerbation. Patients are advised to adhere to prescribed dosing schedules and report any adverse reactions promptly.